ArticleThe oncologist2025

Coverage of actionable alterations in non-small cell lung cancer by hybrid capture-based FoundationOne®CDx compared with amplicon-based OncomineDX.

Kuei-Ting Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.